Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
Clinical trial NCT02402699 · COMPLETED
Trial details
- NCT number
- NCT02402699
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-15
- Primary completion
- 2017-03-23
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.